Blade Air Mobility Inc Stock Price, News & Analysis

Welcome to our dedicated page for Blade Air Mobility news (Ticker: BLDE), a resource for investors and traders seeking the latest updates and insights on Blade Air Mobility stock.

The BLDE news page on Stock Titan aggregates historical and transitional news for Blade Air Mobility, Inc., a technology-powered air mobility platform that has changed its corporate name to Strata Critical Medical, Inc. Company press releases describe Blade as providing air transportation and logistics for hospitals across the United States, where it is one of the largest transporters of human organs for transplant, and arranging passenger flights using helicopters and fixed-wing aircraft in the Northeast United States, Southern Europe and Western Canada.

News items for BLDE cover several key themes. Investors can review announcements about financial results, such as quarterly earnings releases furnished on Form 8-K, which discuss revenue trends, segment performance in Medical and Passenger operations, and non-GAAP metrics like Adjusted EBITDA and Flight Profit. Other articles highlight strategic transactions, including the agreement to sell Blade’s Passenger division to Joby Aviation and the subsequent completion of that sale, as well as the company’s rebranding and name change to Strata Critical Medical, Inc. with a new Nasdaq ticker symbol.

Coverage also includes capital markets and conference participation, where Blade executives present at technology, eVTOL and advanced air mobility events hosted by firms such as Oppenheimer, Jefferies, Ladenburg Thalmann and J.P. Morgan. Additional news features advanced air mobility milestones, such as Blade’s participation in an electric passenger flight using BETA Technologies’ ALIA CTOL aircraft, underscoring the company’s focus on quiet, emission-free air mobility.

By following BLDE news, readers can trace the evolution from a combined passenger and medical air mobility platform to a focused medical logistics business under the Strata Critical Medical name, and monitor how strategic partnerships, regulatory filings and operational updates have shaped that transition.